Skip to main content
Earnings Labs
DiaMedica Therapeutics Inc. logo

DiaMedica Therapeutics Inc. (DMAC)

NASDAQ·Healthcare·Biotechnology

$6.47

-0.31%

Mkt Cap $348.63M

Analyst Ratings

Buy

1

Hold

0

Sell

0

Price Target (3 analysts)

$8.33

Range $7.00$10.00

Implied Upside

+28.7%

Consensus $8.33 vs current $6.47